AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Nov 15, 2023
3114_iss_2023-11-15_50bab4ca-ad92-450c-a222-c4cec3eea09d.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer SynAct Pharma AB
Holder
Thomas Jonassen
Instrument
| Instrument | Ordinary SE0008241491 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 4,722,276 | ||
| Voting rights | 4,722,276 | ||
| Transaction | |||
| Reason for major shareholding notification Sell | |||
| Date | 10/11/2023 | ||
| Limit for number of shares | 5 % | ||
| Limit for number of votes | 5 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 1,190,632 | ||
| Directly held voting rights | 0 | ||
| Indirectly held voting rights | 1,190,632 | ||
| Percentage | |||
| Directly held shares | 3.3472 % | ||
| Directly held voting rights | 0 % | ||
| Indirectly held voting rights | 3.3472 % | ||
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|||||
|---|---|---|---|---|---|---|
| Shares | 3.3472 % | 1,190,632 | ||||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first | |||||
| first paragraph, line 3 | Instruments - FITA Ch. 4, section 2, | |||||
| - Physically settled | ||||||
| - Cash settled | ||||||
| Total | 3.3472 % | 1,190,632 | ||||
| Chain of |
controlling | companies | ||||
| Voting rights % Voting rights Company 1,161,777 3.26608 |
||||||
| 28,855 | 0.08112 | Goodwind Holding Gmbh TJ Biotech Holding ApS |
||||
| Group total |
holdings | |||||
| Voting rights 1,190,632 |
||||||
| Percentage of voting rights 3.3472 | ||||||
| Published | ||||||
| 15/11/2023 11:04 |

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report (ESEF)
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2